These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12439799)

  • 21. Invasive infections caused by non-Aspergillus moulds identified by sequencing analysis at a tertiary care hospital in Taiwan, 2000-2008.
    Hsiue HC; Ruan SY; Kuo YL; Huang YT; Hsueh PR
    Clin Microbiol Infect; 2010 Aug; 16(8):1204-6. PubMed ID: 19886903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agricultural systems as potential sources of emerging human mycoses caused by Trichoderma: a successful, common phylotype of Trichoderma longibrachiatum in the frontline.
    Hatvani L; Homa M; Chenthamara K; Cai F; Kocsubé S; Atanasova L; Mlinaric-Missoni E; Manikandan P; Revathi R; Dóczi I; Bogáts G; Narendran V; Büchner R; Vágvölgyi C; Druzhinina IS; Kredics L
    FEMS Microbiol Lett; 2019 Nov; 366(21):. PubMed ID: 31816013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China.
    Xie L; Zhai H; Zhao J; Sun S; Shi W; Dong X
    Am J Ophthalmol; 2008 Aug; 146(2):260-265. PubMed ID: 18547535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antifungal susceptibility of Acremonium species using E-test and Sensititre].
    Saldarreaga A; Garcia Martos P; Ruiz Aragón J; García Agudo L; Montes de Oca M; Puerto JL; Marín P
    Rev Esp Quimioter; 2004 Mar; 17(1):44-7. PubMed ID: 15201923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Aspergillus species in oral tissue samples of patients with hematologic malignancies by in situ hybridization: a preliminary report.
    Myoken Y; Sugata T; Mikami Y; Murayama SY; Fujita Y
    J Oral Maxillofac Surg; 2008 Sep; 66(9):1905-12. PubMed ID: 18718399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical importance of the genus Trichoderma. A review.
    Kredics L; Antal Z; Dóczi I; Manczinger L; Kevei F; Nagy E
    Acta Microbiol Immunol Hung; 2003; 50(2-3):105-17. PubMed ID: 12894482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of invasive fungal infections in immunocompromised children.
    Dornbusch HJ; Groll A; Walsh TJ
    Clin Microbiol Infect; 2010 Sep; 16(9):1328-34. PubMed ID: 20678175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing strategies for the management of invasive fungal infections.
    Rapp RP
    Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in invasive fungal infections, with emphasis on invasive aspergillosis.
    Erjavec Z; Kluin-Nelemans H; Verweij PE
    Clin Microbiol Infect; 2009 Jul; 15(7):625-33. PubMed ID: 19673973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk factors and outcome of fungal peritonitis in continuous ambulatory peritoneal dialysis patients.
    Indhumathi E; Chandrasekaran V; Jagadeswaran D; Varadarajan M; Abraham G; Soundararajan P
    Indian J Med Microbiol; 2009; 27(1):59-61. PubMed ID: 19172063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.
    Steinbach WJ; Reedy JL; Cramer RA; Perfect JR; Heitman J
    Nat Rev Microbiol; 2007 Jun; 5(6):418-30. PubMed ID: 17505522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fungal blood stream infection, its pathogen and antifungal susceptibility in cancer patients].
    Fujihara S; Imataki O; Tamai Y; Kawakami K
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2383-7. PubMed ID: 19098407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of culture with histopathology in fungal burn wound colonization and infection.
    Schofield CM; Murray CK; Horvath EE; Cancio LC; Kim SH; Wolf SE; Hospenthal DR
    Burns; 2007 May; 33(3):341-6. PubMed ID: 17321689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin.
    Matsue K; Uryu H; Koseki M; Asada N; Takeuchi M
    Clin Infect Dis; 2006 Mar; 42(6):753-7. PubMed ID: 16477548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nosocomial fungal infections, analysis of 149 cases].
    Liu ZY; Sheng RY; Li XL; Li TS; Wang AX
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):399-402. PubMed ID: 12820917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phaeohyphomycosis in a tertiary care cancer center.
    Ben-Ami R; Lewis RE; Raad II; Kontoyiannis DP
    Clin Infect Dis; 2009 Apr; 48(8):1033-41. PubMed ID: 19267655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candida lusitaniae infections in the era of fluconazole availability.
    Hawkins JL; Baddour LM
    Clin Infect Dis; 2003 Jan; 36(2):e14-8. PubMed ID: 12522762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fungal keratitis in London: microbiological and clinical evaluation.
    Galarreta DJ; Tuft SJ; Ramsay A; Dart JK
    Cornea; 2007 Oct; 26(9):1082-6. PubMed ID: 17893539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of fungal infections in the immunocompromised host.
    Mahfouz T; Anaissie E
    Curr Opin Investig Drugs; 2003 Aug; 4(8):974-90. PubMed ID: 14508882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.